18915 results
-
List item
Human medicine European public assessment report (EPAR): Beovu (updated)
brolucizumab, Wet Macular Degeneration
Date of authorisation: 13/02/2020,
, Revision: 4, Authorised, Last updated: 20/01/2022
-
List item
Human medicine European public assessment report (EPAR): Desloratadine ratiopharm (updated)
desloratadine, Rhinitis, Allergic, Perennial; Urticaria; Rhinitis, Allergic, Seasonal
Date of authorisation: 13/01/2012,
, Revision: 10, Authorised, Last updated: 20/01/2022
-
List item
Veterinary medicine European public assessment report (EPAR): Syvazul BTV (updated)
Inactivated bluetongue virus, serotype 1, strain ALG2006/01 E1, Inactivated bluetongue virus, serotype 4, strain BTV-4/SPA-1/2004, Inactivated bluetongue virus, serotype 8, strain BEL2006/01, Cattle; Sheep
Date of authorisation: 09/01/2019, Revision: 3, Authorised, Last updated: 20/01/2022 -
List item
Human medicine European public assessment report (EPAR): Voraxaze (updated)
glucarpidase, Metabolic Side Effects of Drugs and Substances
Date of authorisation: 11/01/2022,, 
, 
, Authorised, Last updated: 20/01/2022
-
List item
Human medicine European public assessment report (EPAR): Pregabalin Zentiva (updated)
pregabalin, Anxiety Disorders; Epilepsy
Date of authorisation: 17/07/2015,, Revision: 12, Authorised, Last updated: 20/01/2022
-
List item
Human medicine European public assessment report (EPAR): Nouryant (updated)
Istradefylline, Parkinson Disease
Date of refusal: 06/01/2022, Refused, Last updated: 19/01/2022 -
List item
Human medicine European public assessment report (EPAR): Efavirenz/Emtricitabine/Tenofovir disoproxil Krka (updated)
efavirenz, emtricitabine, tenofovir disoproxil succinate, HIV Infections
Date of authorisation: 08/02/2018,, Revision: 7, Authorised, Last updated: 19/01/2022
-
List item
Human medicine European public assessment report (EPAR): Inhixa (updated)
enoxaparin sodium, Venous Thromboembolism
Date of authorisation: 15/09/2016,
, Revision: 21, Authorised, Last updated: 19/01/2022
-
List item
Human medicine European public assessment report (EPAR): Takhzyro (updated)
lanadelumab, Angioedemas, Hereditary
Date of authorisation: 22/11/2018,, 
, , Revision: 7, Authorised, Last updated: 19/01/2022
-
List item
Human medicine European public assessment report (EPAR): Klisyri (updated)
tirbanibulin, Keratosis, Actinic
Date of authorisation: 16/07/2021,, Revision: 1, Authorised, Last updated: 19/01/2022
-
List item
Human medicine European public assessment report (EPAR): Ytracis (updated)
yttrium (90Y) chloride, Radionuclide Imaging
Date of authorisation: 24/03/2003, Revision: 7, Withdrawn, Last updated: 19/01/2022 -
List item
Human medicine European public assessment report (EPAR): Evrysdi (updated)
Risdiplam, Muscular Atrophy, Spinal
Date of authorisation: 26/03/2021,, , Revision: 1, Authorised, Last updated: 19/01/2022
-
List item
Human medicine European public assessment report (EPAR): Skyrizi (updated)
Risankizumab, Psoriasis; Arthritis, Psoriatic
Date of authorisation: 26/04/2019,, Revision: 10, Authorised, Last updated: 19/01/2022
-
List item
Human medicine European public assessment report (EPAR): Orencia (updated)
Abatacept, Arthritis, Psoriatic; Arthritis, Juvenile Rheumatoid; Arthritis, Rheumatoid
Date of authorisation: 21/05/2007, Revision: 36, Authorised, Last updated: 19/01/2022 -
List item
Human medicine European public assessment report (EPAR): Pregabalin Pfizer (updated)
pregabalin, Anxiety Disorders; Epilepsy
Date of authorisation: 10/04/2014, Revision: 25, Authorised, Last updated: 19/01/2022 -
List item
Human medicine European public assessment report (EPAR): Lyrica (updated)
pregabalin, Epilepsy; Anxiety Disorders; Neuralgia
Date of authorisation: 05/07/2004, Revision: 53, Authorised, Last updated: 19/01/2022 -
List item
Human medicine European public assessment report (EPAR): Tenofovir disoproxil Zentiva (updated)
tenofovir disoproxil phosphate, HIV Infections
Date of authorisation: 15/09/2016,, Revision: 10, Authorised, Last updated: 19/01/2022
-
List item
Human medicine European public assessment report (EPAR): ellaOne (updated)
ulipristal, Contraception, Postcoital
Date of authorisation: 15/05/2009, Revision: 23, Authorised, Last updated: 19/01/2022 -
List item
Human medicine European public assessment report (EPAR): Onpattro (updated)
patisiran sodium, Amyloidosis, Familial
Date of authorisation: 27/08/2018,, , , Revision: 9, Authorised, Last updated: 19/01/2022
-
List item
Human medicine European public assessment report (EPAR): Clopidogrel Viatris (previously Clopidogrel Taw Pharma) (updated)
clopidogrel besilate, Peripheral Vascular Diseases; Stroke; Myocardial Infarction
Date of authorisation: 16/10/2009,, Revision: 23, Authorised, Last updated: 19/01/2022
-
List item
Human medicine European public assessment report (EPAR): Feraccru (updated)
ferric maltol, Anemia, Iron-Deficiency
Date of authorisation: 18/02/2016, Revision: 15, Authorised, Last updated: 18/01/2022 -
List item
Human medicine European public assessment report (EPAR): Celsentri (updated)
maraviroc, HIV Infections
Date of authorisation: 18/09/2007, Revision: 27, Authorised, Last updated: 18/01/2022 -
List item
Human medicine European public assessment report (EPAR): Xofluza (updated)
Baloxavir marboxil, Influenza, Human
Date of authorisation: 07/01/2021,, Revision: 1, Authorised, Last updated: 18/01/2022
-
List item
Human medicine European public assessment report (EPAR): Pregabalin Mylan (updated)
pregabalin, Anxiety Disorders; Epilepsy
Date of authorisation: 24/06/2015,, Revision: 11, Authorised, Last updated: 18/01/2022
-
List item
Human medicine European public assessment report (EPAR): Pregabalin Zentiva k.s. (updated)
pregabalin, Anxiety Disorders; Neuralgia; Epilepsy
Date of authorisation: 27/02/2017,, Revision: 10, Authorised, Last updated: 18/01/2022